Orsobio, Inc.

United States of America

 
Total IP 12
Total IP Rank # 127,574
IP Activity Score 1.9/5.0    13
IP Activity Rank # 67,245
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

8 1
1 0
2 0
0
 
Last Patent 2025 - Novel aminocarboxymuconate semia...
First Patent 2017 - Oxopyridine derivatives useful a...
Last Trademark 2022 - ORSOBIO
First Trademark 2022 - ORSOBIO

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Novel aminocarboxymuconate semialdehyde decarboxylase inhibitors. Disclosed herein are inhibitors...
Invention Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives. Provided is a compound of Formula...
Invention Novel lxr modulators with bicyclic core moiety. The present invention relates to bicyclic compou...
2023 Invention Lxr modulators with bicyclic core moiety for treating dyslipidemias. The present disclosure relat...
Invention Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (acmsd) inhibit...
Invention Lxr modulators with bicyclic core moiety. The present invention relates to bicyclic compounds (e....
2022 G/S Human pharmaceutical preparations for the prevention and treatment of metabolic disorders and dis...
2021 Invention Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives. Provided is a compound of Formula ...
2019 Invention Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives. The present disclosure relates to ...